These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32928894)

  • 41. Expanding the clinical and molecular spectrum of lethal congenital contracture syndrome 8 associated with biallelic variants of ADCY6.
    Agolini E; Cherchi C; Bellacchio E; Martinelli D; Cocciadiferro D; Cutrera R; Chiarini Testa MB; Barone C; Bianca S; Novelli A
    Clin Genet; 2020 Apr; 97(4):649-654. PubMed ID: 31846058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome.
    Niibori Y; Lee SJ; Minassian BA; Hampson DR
    Hum Gene Ther; 2020 Mar; 31(5-6):339-351. PubMed ID: 31830809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dravet syndrome and its mimics: Beyond SCN1A.
    Steel D; Symonds JD; Zuberi SM; Brunklaus A
    Epilepsia; 2017 Nov; 58(11):1807-1816. PubMed ID: 28880996
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical implications of SCN1A missense and truncation variants in a large Japanese cohort with Dravet syndrome.
    Ishii A; Watkins JC; Chen D; Hirose S; Hammer MF
    Epilepsia; 2017 Feb; 58(2):282-290. PubMed ID: 28012175
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of five novel
    Zeng B; Zhang H; Lu Q; Fu Q; Yan Y; Lu W; Ma P; Feng C; Qin J; Luo L; Yang B; Zou Y; Liu Y
    Front Behav Neurosci; 2023; 17():1272748. PubMed ID: 38025388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo, in vitro and in silico correlations of four de novo SCN1A missense mutations.
    Nissenkorn A; Almog Y; Adler I; Safrin M; Brusel M; Marom M; Bercovich S; Yakubovich D; Tzadok M; Ben-Zeev B; Rubinstein M
    PLoS One; 2019; 14(2):e0211901. PubMed ID: 30735520
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Genetic and phenotypic characteristics of SCN1A mutations in Dravet syndrome].
    Xu XJ; Zhang YH; Sun HH; Liu XY; Jiang YW; Wu XR
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):625-30. PubMed ID: 23225037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel SCN1A variants in Dravet syndrome and evaluating a wide approach of patient selection.
    Surovy M; Soltysova A; Kolnikova M; Sykora P; Ilencikova D; Ficek A; Radvanszky J; Kadasi L
    Gen Physiol Biophys; 2016 Jul; 35(3):333-42. PubMed ID: 27045673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice.
    Hawkins NA; Jurado M; Thaxton TT; Duarte SE; Barse L; Tatsukawa T; Yamakawa K; Nishi T; Kondo S; Miyamoto M; Abrahams BS; During MJ; Kearney JA
    Epilepsia; 2021 Nov; 62(11):2845-2857. PubMed ID: 34510432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Co-occurring malformations of cortical development and SCN1A gene mutations.
    Barba C; Parrini E; Coras R; Galuppi A; Craiu D; Kluger G; Parmeggiani A; Pieper T; Schmitt-Mechelke T; Striano P; Giordano F; Blumcke I; Guerrini R
    Epilepsia; 2014 Jul; 55(7):1009-19. PubMed ID: 24902755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A mild phenotype of LGI4-Related arthrogryposis multiplex congenita with intrafamilial variability.
    Mishra S; Rai A; Srivastava P; Phadke SR
    Eur J Med Genet; 2020 Mar; 63(3):103756. PubMed ID: 31513940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aberrant regulation of a poison exon caused by a non-coding variant in a mouse model of Scn1a-associated epileptic encephalopathy.
    Voskobiynyk Y; Battu G; Felker SA; Cochran JN; Newton MP; Lambert LJ; Kesterson RA; Myers RM; Cooper GM; Roberson ED; Barsh GS
    PLoS Genet; 2021 Jan; 17(1):e1009195. PubMed ID: 33411788
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation.
    Ricobaraza A; Mora-Jimenez L; Puerta E; Sanchez-Carpintero R; Mingorance A; Artieda J; Nicolas MJ; Besne G; Bunuales M; Gonzalez-Aparicio M; Sola-Sevilla N; Valencia M; Hernandez-Alcoceba R
    Sci Rep; 2019 Oct; 9(1):14172. PubMed ID: 31578435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expanding spectrum of SCN1A-related phenotype with novel mutations.
    Hız-Kurul S; Gürsoy S; Ayanoğlu M; Yiş U; Erçal D
    Turk J Pediatr; 2017; 59(5):570-575. PubMed ID: 29745119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A mutation in GABRB3 associated with Dravet syndrome.
    Le SV; Le PHT; Le TKV; Kieu Huynh TT; Hang Do TT
    Am J Med Genet A; 2017 Aug; 173(8):2126-2131. PubMed ID: 28544625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SCN1A clinical spectrum includes the self-limited focal epilepsies of childhood.
    Kivity S; Oliver KL; Afawi Z; Damiano JA; Arsov T; Bahlo M; Berkovic SF
    Epilepsy Res; 2017 Mar; 131():9-14. PubMed ID: 28192756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phenotypic spectrum of the SCN1A mutation (from febrile seizures to Dravet syndrome).
    Ceska K; Danhofer P; Horak O; Spanelova K; Kolar S; Oslejskova H; Aulicka S
    Bratisl Lek Listy; 2022; 123(7):483-486. PubMed ID: 35907053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. De novo SCN1A mutations in migrating partial seizures of infancy.
    Carranza Rojo D; Hamiwka L; McMahon JM; Dibbens LM; Arsov T; Suls A; Stödberg T; Kelley K; Wirrell E; Appleton B; Mackay M; Freeman JL; Yendle SC; Berkovic SF; Bienvenu T; De Jonghe P; Thorburn DR; Mulley JC; Mefford HC; Scheffer IE
    Neurology; 2011 Jul; 77(4):380-3. PubMed ID: 21753172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetics and clinical correlation of Dravet syndrome and its mimics - experience of a tertiary center in Taiwan.
    Liu YH; Cheng YT; Tsai MH; Chou IJ; Hung PC; Hsieh MY; Wang YS; Chen YJ; Kuo CY; Lin JJ; Wang HS; Lin KL
    Pediatr Neonatol; 2021 Sep; 62(5):550-558. PubMed ID: 34226156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathogenic significance of SCN1A splicing variants causing Dravet syndrome: Improving diagnosis with targeted sequencing for variants by in silico analysis.
    Mahdieh N; Mikaeeli S; Badv RS; Shirazi AG; Maleki M; Rabbani B
    Clin Neurol Neurosurg; 2018 Mar; 166():80-90. PubMed ID: 29408779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.